Hantz Financial Services, Inc. Amphastar Pharmaceuticals, Inc. Transaction History
Hantz Financial Services, Inc.
- $6.19 Billion
- Q2 2025
A detailed history of Hantz Financial Services, Inc. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 1,377 shares of AMPH stock, worth $35,567. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,377
Previous 39
3430.77%
Holding current value
$35,567
Previous $1,000
3100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AMPH
# of Institutions
257Shares Held
33.3MCall Options Held
18.3KPut Options Held
12.6K-
Black Rock Inc. New York, NY5.94MShares$153 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$69.4 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$52.6 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$42 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$40.7 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.27B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...